Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben L Osnabrugge

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Trends in Cardiovascular Medicine|August 26, 2017
Long-term outlook for transcatheter aortic valve replacementAndras P Durko, Ruben L Osnabrugge, A Pieter Kappetein
European Heart Journal|March 17, 2018
Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projectionsAndras P Durko, Ruben L Osnabrugge, Nicolas M Van Mieghem, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 28, 2014
Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantationRuben L Osnabrugge, Alan M Speir, Stuart J Head, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2014
A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel usersRuben L Osnabrugge, Stuart J Head, Felix Zijlstra, et al.
The Annals of Thoracic Surgery|August 12, 2014
Prediction of costs and length of stay in coronary artery bypass graftingRuben L Osnabrugge, Alan M Speir, Stuart J Head, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 21, 2014
Cost, quality, and value in coronary artery bypass graftingRuben L Osnabrugge, Alan M Speir, Stuart J Head, et al.
Journal of the American College of Cardiology|April 22, 2017
Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main DiseaseMouin S Abdallah, Kaijun Wang, Elizabeth A Magnuson, et al.
Circulation|August 3, 2014
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trialDavid J Cohen, Ruben L Osnabrugge, Elizabeth A Magnuson, et al.
JACC. Cardiovascular Interventions|February 22, 2015
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trialRuben L Osnabrugge, Suzanne V Arnold, Matthew R Reynolds, et al.
Heart (British Cardiac Society)|November 11, 2015
Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspectiveRuben L Osnabrugge, Elizabeth A Magnuson, Patrick W Serruys, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Trends in Cardiovascular Medicine|August 26, 2017
Long-term outlook for transcatheter aortic valve replacementAndras P Durko, Ruben L Osnabrugge, A Pieter Kappetein
European Heart Journal|March 17, 2018
Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projectionsAndras P Durko, Ruben L Osnabrugge, Nicolas M Van Mieghem, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 28, 2014
Performance of EuroSCORE II in a large US database: implications for transcatheter aortic valve implantationRuben L Osnabrugge, Alan M Speir, Stuart J Head, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 20, 2014
A systematic review and critical assessment of 11 discordant meta-analyses on reduced-function CYP2C19 genotype and risk of adverse clinical outcomes in clopidogrel usersRuben L Osnabrugge, Stuart J Head, Felix Zijlstra, et al.
The Annals of Thoracic Surgery|August 12, 2014
Prediction of costs and length of stay in coronary artery bypass graftingRuben L Osnabrugge, Alan M Speir, Stuart J Head, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 21, 2014
Cost, quality, and value in coronary artery bypass graftingRuben L Osnabrugge, Alan M Speir, Stuart J Head, et al.
Journal of the American College of Cardiology|April 22, 2017
Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main DiseaseMouin S Abdallah, Kaijun Wang, Elizabeth A Magnuson, et al.
Circulation|August 3, 2014
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trialDavid J Cohen, Ruben L Osnabrugge, Elizabeth A Magnuson, et al.
JACC. Cardiovascular Interventions|February 22, 2015
Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trialRuben L Osnabrugge, Suzanne V Arnold, Matthew R Reynolds, et al.
Heart (British Cardiac Society)|November 11, 2015
Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspectiveRuben L Osnabrugge, Elizabeth A Magnuson, Patrick W Serruys, et al.
Pageof 1